Last reviewed · How we verify

Accelerated 30 minutes-infusion — Competitive Intelligence Brief

Accelerated 30 minutes-infusion (Accelerated 30 minutes-infusion) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

Accelerated 30 minutes-infusion (Accelerated 30 minutes-infusion) — Asan Medical Center. This drug works by inhibiting the PD-1 receptor, which is involved in immune suppression.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Accelerated 30 minutes-infusion TARGET Accelerated 30 minutes-infusion Asan Medical Center marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Accelerated 30 minutes-infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/accelerated-30-minutes-infusion. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: